US 12338231
N-heterocycle substituted tryptamine derivatives and methods of using
granted A61KA61K31/4045A61K31/496
Quick answer
US patent 12338231 (N-heterocycle substituted tryptamine derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enveric Biosciences Canada Inc.
- Grant date
- Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/4045, A61K31/496, A61K31/5377